Correlation Between DOD Biotech and Inter Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both DOD Biotech and Inter Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DOD Biotech and Inter Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DOD Biotech Public and Inter Pharma Public, you can compare the effects of market volatilities on DOD Biotech and Inter Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DOD Biotech with a short position of Inter Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of DOD Biotech and Inter Pharma.

Diversification Opportunities for DOD Biotech and Inter Pharma

0.86
  Correlation Coefficient

Very poor diversification

The 3 months correlation between DOD and Inter is 0.86. Overlapping area represents the amount of risk that can be diversified away by holding DOD Biotech Public and Inter Pharma Public in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inter Pharma Public and DOD Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DOD Biotech Public are associated (or correlated) with Inter Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inter Pharma Public has no effect on the direction of DOD Biotech i.e., DOD Biotech and Inter Pharma go up and down completely randomly.

Pair Corralation between DOD Biotech and Inter Pharma

Assuming the 90 days trading horizon DOD Biotech Public is expected to under-perform the Inter Pharma. But the stock apears to be less risky and, when comparing its historical volatility, DOD Biotech Public is 1.05 times less risky than Inter Pharma. The stock trades about -0.27 of its potential returns per unit of risk. The Inter Pharma Public is currently generating about -0.19 of returns per unit of risk over similar time horizon. If you would invest  404.00  in Inter Pharma Public on August 26, 2024 and sell it today you would lose (44.00) from holding Inter Pharma Public or give up 10.89% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

DOD Biotech Public  vs.  Inter Pharma Public

 Performance 
       Timeline  
DOD Biotech Public 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in DOD Biotech Public are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting fundamental indicators, DOD Biotech disclosed solid returns over the last few months and may actually be approaching a breakup point.
Inter Pharma Public 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Inter Pharma Public are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting fundamental drivers, Inter Pharma disclosed solid returns over the last few months and may actually be approaching a breakup point.

DOD Biotech and Inter Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with DOD Biotech and Inter Pharma

The main advantage of trading using opposite DOD Biotech and Inter Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DOD Biotech position performs unexpectedly, Inter Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inter Pharma will offset losses from the drop in Inter Pharma's long position.
The idea behind DOD Biotech Public and Inter Pharma Public pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Stocks Directory
Find actively traded stocks across global markets
Global Correlations
Find global opportunities by holding instruments from different markets